[Megakaryoblastic acute leukemia: bone and joint manifestations in a 7-month-old child]

F Chambon1, C Paillard, E Doré

  • 1Centre régional de cancérologie et thérapie cellulaire pédiatrique, hôpital Estaing, CHU de Clermont-Ferrand, BP 69, 1, place Lucie-Aubrac, 63001 Clermont-Ferrand, France.

Insights

Diagnosing childhood acute megakaryoblastic leukemia can be challenging due to myelofibrosis. This case highlights indirect diagnostic clues and eventual confirmation in a 7-month-old infant.

Area of Science:

  • Pediatric Hematology Oncology
  • Leukemia Research

Background:

  • Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML) in children, comprising 3-10% of cases.
  • Diagnosis can be complicated by myelofibrosis, a condition involving bone marrow scarring.

Observation:

  • A 7-month-old infant presented with hepatomegaly, bicytopenia, bone pain, and recurrent aseptic arthritis.
  • Initial bone marrow investigations were inconclusive due to sampling issues and lack of abnormal cells in morphology, immunophenotyping, and cytogenetics.
  • Indirect evidence included radiographic findings (periosteal new bone, lytic lesions) and bone marrow biopsy showing myelofibrosis and micromegakaryocytes.

Findings:

  • Despite diagnostic challenges, megakaryoblasts were eventually identified in bone marrow aspirate smears after over two months of investigation.
  • The findings supported an early suspicion of AMKL.

Implications:

  • This case underscores the importance of considering AMKL in infants with suggestive clinical and radiological findings, even with initially negative bone marrow results.
  • Early suspicion and persistent investigation are crucial for timely diagnosis and treatment initiation in challenging pediatric leukemia cases.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...